231 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

BOVN.F

BioInvent International
kr4.700%n/akr2.7bkr12.58PS9.2xE62.0%n/a

IDD

Innate Pharma
€2.13-6.2%-27.6%€173.8m€6.21PS2.8xE33.0%n/a

BIX0

BioInvent International
kr1.8114.9%-26.1%kr1.6bkr6.27PS22.1xE60.1%n/a

08D

Mirum Pharmaceuticals
US$22.20-5.9%-5.1%US$1.1bUS$45.53PS6xE65.4%n/a

RCEL

AVITA Medical
US$8.87-14.3%-38.1%US$228.8mUS$26.90PS4.6xE63.4%n/a

GTHX

G1 Therapeutics
US$4.17-10.9%46.8%US$217.7mUS$8.50PS2.6xE55.1%n/a

S1GE34

Seagen
US$56.706.7%n/aUS$43.2bUS$56.74PS18.8xE71.8%n/a

P0F

Egetis Therapeutics
kr0.49-6.1%-32.9%kr1.8bkr1.04PS31.4xE85.4%n/a

SGEN

Seagen
US$228.744.5%76.5%US$43.2bUS$228.91PS18.8xE71.8%n/a

0A8R

Seagen
US$228.954.6%81.1%US$43.2bUS$229.12PS18.8xE71.8%n/a

IMGN

ImmunoGen
US$31.236.6%617.9%US$8.4bUS$28.95PS29.1xE45.8%n/a

IMGN *

ImmunoGen
US$268.500%96.1%US$8.4bUS$248.87PS29.1xE45.2%n/a

IPHY.F

Innate Pharma
€2.650%n/a€174.6m€7.69PS2.8xE30.0%n/a

0ABW

Egetis Therapeutics
kr6.04-11.8%-22.0%kr1.8bkr13.13PS30.7xE85.4%n/a

AVHH.L

AVITA Medical
US$2.10-34.4%-22.2%US$242.0mUS$6.37PS4.6xE63.4%n/a

0H22

BioInvent International
kr23.5326.3%-20.0%kr1.6bkr81.53PS22.1xE60.1%n/a

SPAGO

Spago Nanomedical
kr0.3421.4%-58.0%kr75.3mn/aPS12.7xE56.0%n/a

AVH

AVITA Medical
US$2.95-26.4%-31.6%US$242.0mUS$8.95PS4.6xE63.4%n/a

A196170

ALTEOGEN
₩176,200.001.6%276.5%₩9.3t₩168,333.33PS96.7xE124.4%n/a

51KA

AVITA Medical
US$8.60-10.9%-34.4%US$242.0mUS$26.08PS4.6xE63.4%n/a

OL0

Devyser Diagnostics
kr8.76-3.5%24.8%kr1.7bkr9.63PS10.1xE99.3%n/a

AVH

AVITA Medical
US$2.95-25.9%-31.2%US$242.0mUS$8.95PS4.6xE63.4%n/a

41X

Ardelyx
US$6.14-6.3%39.1%US$1.5bUS$12.65PS12.2xE59.6%n/a

DVYSR

Devyser Diagnostics
kr105.00-1.4%25.3%kr1.7bkr115.39PS10.1xE99.3%n/a
Page 1 of 10
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.